Last updated: May 18, 2022
Sponsor: University of Aarhus
Overall Status: Active - Recruiting
Phase
N/A
Condition
Pneumonia
Lung Cancer
Cancer
Treatment
N/AClinical Study ID
NCT04676828
KFE-1930
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- histologically verified lung cancer (small-cell and non-small cell lung cancer)
- referred for radiotherapy with curative intent
- radiation dose of 60-66 Gy given in 2-Gy fractions, other dose levels andfractionation schedules accepted, as per site standard
- concurrent chemotherapy is accepted
- patients with oligometastatic disease are allowed, where metastasis have been ablatedwith surgery or radiotherapy
- receiving (chemo)-radiotherapy to the thoracic disease with curative intent
- adults over 18, that have given oral and written informed consent before patientregistration.
Exclusion
Exclusion Criteria:
- concurrent immunotherapy
- previous radiotherapy to the thorax
- other uncontrolled malignancies; any psychological, familial, sociological orgeographical condition potentially hampering compliance with the study protocol
Study Design
Total Participants: 195
Study Start date:
December 01, 2020
Estimated Completion Date:
December 01, 2024
Study Description
Connect with a study center
Sydney West Radiation Oncology Network Westmead and Blacktown Hospitals
Sydney, New South Wales 2145
AustraliaSite Not Available
Department of Oncology, Aarhus University Hospital
Aarhus, DK-8000
DenmarkActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.